Bygbjerg I C, Svenson M, Theander T G, Bendtzen K
Int J Immunopharmacol. 1987;9(4):513-9. doi: 10.1016/0192-0561(87)90027-0.
Effect of pyrimethamine, an antimalarial antifolate, and of mefloquine, chloroquine, and quinine, which belong to the quinoline group of antimalarials, on proliferation and interleukin 2 (IL-2) production of human lymphocytes was studied in vitro. Pyrimethamine at concentrations above therapeutic levels suppressed the lymphocytes' proliferation, but not their IL-2 production. All three quinolines suppressed the proliferation of lymphocytes, but not equally, with mefloquine having the strongest effect. Quinine suppressed the growth at therapeutic concentrations. The IL-2 production was suppressed at concentrations twice as high as those required to suppress lymphocyte proliferation. Addition of exogenous IL-2 only partially reversed the suppressive effect on lymphocyte proliferation. Delayed addition of the quinolines decreased their suppressive effect, but not completely. The mechanisms of action on human mononuclear cells of the various antimalarial drugs and the potential adverse effects of antimalarial chemotherapy are discussed.
研究了抗疟抗叶酸药物乙胺嘧啶以及属于喹啉类抗疟药的甲氟喹、氯喹和奎宁对人淋巴细胞增殖及白细胞介素2(IL-2)产生的体外影响。高于治疗水平浓度的乙胺嘧啶抑制淋巴细胞增殖,但不抑制其IL-2产生。所有三种喹啉类药物均抑制淋巴细胞增殖,但程度不同,其中甲氟喹的作用最强。奎宁在治疗浓度时抑制生长。IL-2产生在抑制淋巴细胞增殖所需浓度的两倍时受到抑制。添加外源性IL-2仅部分逆转对淋巴细胞增殖的抑制作用。喹啉类药物延迟添加会降低其抑制作用,但不能完全消除。讨论了各种抗疟药物对人单核细胞的作用机制以及抗疟化疗的潜在不良反应。